S3469Referred to Committee

BIOSECURE Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-12-11
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Gary C. Peters
Gary C. Peters
Democrat · MI · Senator
Votes with party: 57.8% (320 recorded votes)

Full profile: /officials/P000595

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

2025-12-11

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would restrict certain Chinese companies and entities from owning or investing in U.S. biotechnology and pharmaceutical businesses, aiming to protect American medical research and drug development from foreign control. It affects biotech startups, pharmaceutical companies, and research institutions that might otherwise receive funding or investment from Chinese sources. The measure reflects concerns about keeping sensitive health and medical technology development within U.S. hands.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.